Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedLocation entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.1%

- Check23 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision tag updated: v3.4.2 added and previous tag v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedSystem revision updated from v3.4.0 to v3.4.1 with no visible changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded an in-page glossary toggle; updated metadata labels to Last Update Submitted that Met QC Criteria and No FEAR Act Data, and updated the revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.